Where is Immusoft headquartered?

Immusoft is located in Seattle, WA.

Who invested in Immusoft?

Immusoft has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Immusoft?

Immusoft closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

immusoft.com

Immusoft

Immusoft is a Washington-based clinical-stage biotechnology company that develops novel therapies for the treatment of genetic diseases.

Business Model:

Revenue: $4M

Employees: 11-50

Geographic Data

Address: 454 N 34th Street

City: Seattle

State: WA

Zip: 98103

Country: US

Financial Info

Stage:

grant

Raised Last:

$4M

Raised Total:

$41M

Social

Twitter

Crunchbase

Metrics

8,816,021Website Global Rank

258Website Monthly Traffic

Twitter Followers

Description

Immusoft is a Washington-based clinical-stage biotechnology company that develops novel therapies for the treatment of genetic diseases.

Contact Phone:
+12063970028

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2019	Series B		$16.4M	Breakout Ventures RBV Capital DEFTA Partners Mesa Verde Venture Partners
9/2009	Angel Round	1	-	Boston Harbor Angels Boston Harbor Angels
1/2018	Series B	6	$3M	600 Mile Challenge Fund Tim Draper Technium Partners Peter Thiel Invariantes Fund EQx Fund 600 Mile Challenge Fund
1/2023	Grant	1	$8M	California Institute for Regenerative Medicine California Institute For Regenerative Medicine California Institute For Regenerative Medicine California Institute For Regenerative Medicine
9/2020	Grant	1	$467k	National Institutes of Health National Institutes of Health
11/2016	Series A	4	$2.7M	FF Science Technium Partners Propel(X) Breakout Ventures FF Science Technium Partners
8/2014	Series A	2	$2.4M	Founders Fund Westcott LLC Founders Fund
9/2018	Grant	1	$3.5M	National Institute of General Medical Science National Institute of General Medical Science
9/2020	Equity		$4.1M	Breakout Ventures Oisin Biotechnologies Zentalis Pharmaceuticals
11/2021	Grant	1	$4M	California Institute for Regenerative Medicine California Institute for Regenerative Medicine
1/2019	Series B		$0	Breakout Ventures Alexandria Venture Investments RBV Capital GRIDS Capital Mesa Verde Venture Partners Bios Partners DEFTA Partners Breakout Ventures Alexandria Venture Investments RBV Capital GRIDS Capital Mesa Verde Venture Partners Bios Partners DEFTA Partners
4/2012	Grant	2	$350k	The Thiel Foundation Breakout Labs
1/2023	Grant		$8M
9/2020	Venture Round		$0	Breakout Ventures Ikarian Capital Mesa Verde Venture Partners Breakout Ventures Ikarian Capital Mesa Verde Venture Partners
8/2015	Debt Financing		$0	Westcott LLC Westcott LLC
9/2020	Venture Round	3	$4.5M	Breakout Ventures Ikarian Capital Mesa Verde Venture Partners Breakout Ventures Ikarian Capital Mesa Verde Venture Partners
1/2019	Series B	7	$20M	Breakout Ventures Alexandria Venture Investments RBV Capital GRIDS Capital Mesa Verde Venture Partners Breakout Ventures Alexandria Venture Investments RBV Capital GRIDS Capital Mesa Verde Venture Partners
8/2015	Debt Financing	1	$375k

Acquisitions

Announced Date	Name	Price
3/2016	Discovery Genomics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details